Common Contracts
2 similar Note contracts by ReShape Lifesciences Inc., Vsee Health, Inc.
SENIOR SECURED CONVERTIBLE PROMISSORY NOTE DUE JANUARY 16, 2025Note • October 17th, 2024 • ReShape Lifesciences Inc. • Pharmaceutical preparations • Delaware
This Senior Secured Convertible Promissory Note is one of a series of duly authorized and validly issued Senior Secured Convertible Promissory Notes of ReShape Lifesciences Inc., a Delaware corporation (the “Company”), designated as its Senior Secured Convertible Promissory Note due January 16, 2025 (this “Note” and, collectively with the other Notes of such series, the “Notes”), issued and sold by the Company pursuant to the Securities Purchase Agreement, dated as of October 16, 2024, by and among the Company, the other Company Parties and _______________ (together with its successors and registered assigns, the “Holder”), a Delaware limited liability company (the “Purchase Agreement”; capitalized terms used but not otherwise defined herein are used as defined in the Purchase Agreement on the date hereof, with such amendments as may be acceptable to the Holder in its sole discretion). This Note is entered into pursuant to the Purchase Agreement and is subject to the terms and conditio
SENIOR SECURED CONVERTIBLE PROMISSORY NOTE DUE MARCH 30, 2026Note • October 1st, 2024 • Vsee Health, Inc. • Services-health services • Delaware
This Senior Secured Convertible Promissory Note is one of a series of duly authorized and validly issued Senior Secured Convertible Promissory Notes of VSee Health, Inc., a Delaware corporation, (the “Company”), designated as its Senior Secured Convertible Promissory Note due March 30, 2026 (this “Note” and, collectively with the other Notes of such series, the “Notes”), issued and sold by the Company pursuant to the Securities Purchase Agreement, dated as of September 30, 2024, by and among the Company, the other Company Parties and [HOLDER] (together with its successors and registered assigns, the “Holder”), a Delaware limited liability company (the “Purchase Agreement”; capitalized terms used but not otherwise defined herein are used as defined in the Purchase Agreement on the date hereof, with such amendments as may be acceptable to the Holder in its sole discretion). This Note is entered into pursuant to the Purchase Agreement and is subject to the terms and conditions thereof.
